A pilot study for treatment of COVID-19 patients in moderate stage using intravenous administration of ozonized saline as an adjuvant treatment-registered clinical trial.
Sharma A, Shah M, Lakshmi S, Sane H, Captain J, Gokulchandran N, Khubchandani P, Pradeep MK, Gote P, Tuppekar B, Kulkarni P, Paranjape A, Pradhan R, Varghese R, Kasekar S, Nair V, Khanbande U.
Sharma A, et al. Among authors: gokulchandran n.
Int Immunopharmacol. 2021 Jul;96:107743. doi: 10.1016/j.intimp.2021.107743. Epub 2021 Apr 30.
Int Immunopharmacol. 2021.
PMID: 33984718
Free PMC article.
Clinical Trial.